NCT06720545View on ClinicalTrials.gov

Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 5, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Obstructive Sleep ApneaObstructive Sleep Apnea of Adult
Interventions
DEVICE

No HGNS therapy (HGNS-off)

Prior to enrollment in this study, participants will have been utilizing HGNS at a therapeutic voltage setting confirmed via overnight sleep study. As part of the trial, they will undergo a study arm that involves turning off HGNS therapy (HGNS-off) for between 2-4 weeks.

Trial Locations (1)

10032

RECRUITING

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

American Academy of Sleep Medicine

OTHER

collaborator

Triological Society

UNKNOWN

collaborator

American Heart Association

OTHER

lead

Columbia University

OTHER